SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-063646
Filing Date
2022-10-13
Accepted
2022-10-13 06:04:50
Documents
6
Period of Report
2022-10-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea167067-6k_alteritytherap.htm 6-K 12180
2 NOTICE OF ANNUAL GENERAL MEETING/PROXY FORM ea167067ex99-1_alterity.htm EX-99.1 185143
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6929
4 GRAPHIC ex99-1_002.jpg GRAPHIC 6261
5 GRAPHIC proxy_001.jpg GRAPHIC 243814
6 GRAPHIC proxy_002.jpg GRAPHIC 232007
  Complete submission text file 0001213900-22-063646.txt   872382
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 221308023
SIC: 2834 Pharmaceutical Preparations